切换至 "中华医学电子期刊资源库"

中华老年骨科与康复电子杂志 ›› 2019, Vol. 05 ›› Issue (01) : 19 -24. doi: 10.3877/cma.j.issn.2096-0263.2019.01.005

所属专题: 文献

髋部骨折

吲哚布芬预防老年髋关节置换术后下肢深静脉血栓的临床研究
胡鸿鹏1, 刘泽明1, 高勇岗1, 马文辉1, 姚孟轩1, 李梦男1, 秦迪1, 李会杰1, 韩永台1,()   
  1. 1. 050051 石家庄,河北医科大学第三医院骨病科
  • 收稿日期:2018-03-15 出版日期:2019-02-05
  • 通信作者: 韩永台

Clinical study of indolbufen in preventing deep vein thrombosis of lower extremity after hip arthroplasty in elderly patients

Hongpeng Hu1, Zeming Liu1, Yonggang Gao1, Wenhui Ma1, Mengxuan Yao1, mengnan Li1, Di Qin1, Huijie Li1, Yongtai Han1,()   

  1. 1. Bone Disease Department, theThirdHospital of Hebei Medical University, Shijiazhuang 050051, China
  • Received:2018-03-15 Published:2019-02-05
  • Corresponding author: Yongtai Han
  • About author:
    Corresponding author: Han Yongtai, Email:
引用本文:

胡鸿鹏, 刘泽明, 高勇岗, 马文辉, 姚孟轩, 李梦男, 秦迪, 李会杰, 韩永台. 吲哚布芬预防老年髋关节置换术后下肢深静脉血栓的临床研究[J/OL]. 中华老年骨科与康复电子杂志, 2019, 05(01): 19-24.

Hongpeng Hu, Zeming Liu, Yonggang Gao, Wenhui Ma, Mengxuan Yao, mengnan Li, Di Qin, Huijie Li, Yongtai Han. Clinical study of indolbufen in preventing deep vein thrombosis of lower extremity after hip arthroplasty in elderly patients[J/OL]. Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), 2019, 05(01): 19-24.

目的

探讨吲哚布芬预防老年患者髋关节置换术后下肢深静脉血栓(DVT)的疗效及安全性。

方法

前瞻性收集河北医科大学第三医院骨病科2017年1月至2017年8月因非外伤性原因行初次全髋关节置换的60岁以上患者100例。随机将100例患者分为两组,A组(50例)采用吲哚布芬200 mg,2/日抗凝治疗,B组(50例)采用利伐沙班10 mg,1/日抗凝治疗,两组抗凝药使用均不少于35 d,观察并对比两组血栓发生率、失血量及凝血功能等指标。

结果

100例中共发生13例DVT,A组6例(12%)术后发生静脉血栓:肌间静脉血栓4例,胫后/腓静脉血栓2例。B组7例(14%)术后发生静脉血栓:肌间静脉血栓5例,胫后/腓静脉血栓2例。两组均未出现腘静脉及腘静脉以上严重血栓。A组和B组下肢DVT发生情况比较,差异无统计学意义(χ2=0.123,P=0.941)。两组患者术后1 d引流量均比2 d多,差异有统计学意义(A组:t=41.901,P<0.05;B组:t=31.185,P<0.05);两组患者术前血红蛋白均正常,术后1 d下降,术后7 d基本和术后1 d持平,组内不同时点间血红蛋白差异有统计学意义(F=17.688,P<0.001),两组间各时间点血红蛋白差异无统计学意义(F=0.724,P=0.399)。两组PT、APTT和INR术后呈上下波动,组内不同时点间差异有统计学意义(F=10.635,P<0.001;F=5.020,P=0.008;F=9.147,P<0.001);两组FIB、D-Dimmer也呈上下波动,组间(F=4.414,P=0.041;F=11.867,P<0.001)及组内不同时点间(F=88.996,P<0.001;F=103.021,P<0.001)差异均有统计学意义。

结论

与利伐沙班相比,吲哚布芬预防老年患者髋关节置换术后下肢DVT发生率相似,不显著增加患者的术后失血。

Objective

To discuss the efficacy and safety of indolbufen in prevention of deep venous thrombosis after hip arthroplasty in elderly patients.

Methods

A total of 100 tramatic patients who underwent primary total hip arthroplasty from January 2017 to August 2017 in the department of orthopedics, the third hospital of hebei medical university were collected. 100 patients were randomly divided into two groups: group A (50 cases) was treated with 200 mg of indolebufen, 2/d, and group B (50 cases) was treated with 10 mg of rivaroxaban and 1/d anticoagulant. Anticoagulants were used for at least 35 days in both groups. We observed and compared the incidence of thrombosis, blood loss and coagulation function between the two groups.

Results

There were 13 DVT in 100 cases. In group A, 6 cases (12%) had postoperative venous thrombosis, 4 cases had intramuscular venous thrombosis, and 2 cases had posterior tibial/peroneal venous thrombosis. In group B, 7 cases (14%) had postoperative venous thrombosis, 5 cases had intramuscular venous thrombosis, and 2 cases had posterior tibial/peroneal venous thrombosis. No serious popliteal vein or femoral vein thrombosis occurred in either group. There was no statistically significant difference between group A and group B in the incidence of lower extremity deep vein thrombosis (χ2=0.123, P=0.941). The drainage of patients in both groups was higher on day 1 after surgery than that on day 2 after surgery, and the difference between the drainage on day 1 after surgery and that on day 2 after surgery was statistically significant (group A: t=41.901, P<0.05; Group B: t= 31.185, P<0.05); Patients in both groups had normal preoperative hemoglobin, decreased hemoglobin on the first day after surgery, and almost equal hemoglobin on the seventh day after surgery and the first day after surgery. There was statistically significant difference in hemoglobin between the two groups at different time points (F=17.688, P<0.001). There was no statistically significant difference in hemoglobin between the two groups at different time points (F=0.724, P=0.399). Postoperative PT, APTT and INR of the two groups fluctuated up and down, with only statistical difference in time points (F=10.635, P<0.001; F=5.020, P=0.008; F=9.147, P<0.001). FIB and d-dimmer also fluctuated up and down in the two groups, and there were statistical differences between the groups (F=4.414, P=0.041; F=11.867, P<0.001) and between the time points (F=88.996, P<0.001; F=103.021, P<0.001).

Conclusion

Compared with rivaroxaban, the incidence of deep vein thrombosis in lower extremities after hip arthroplasty was similar in indobufen prevention in elderly patients, with no significant increase in postoperative blood loss.

表1 吲哚布芬组和利伐沙班组髋关节置换患者一般资料比较
表2 两组髋关节置换患者下肢深静脉血栓发生率比较
表3 两组髋关节置换患者不同时间点引流量比较(ml,±s
表4 两组髋关节置换患者不同时间点血红蛋白比较(g/L,±s
表5 两组髋关节置换患者不同时间点凝血酶原时间比较(S,±s
表6 两组髋关节置换患者不同时间点部分凝血活酶时间比较(S,±s
表7 两组髋关节置换患者不同时间点纤维蛋白原比较(g/L,±s
表8 两组髋关节置换患者不同时间点国际标准化比值比较(±s
表9 两组髋关节置换患者不同时间点D-二聚体比较(mg/L,±s
1
Zhang H, Mao P, Wang C, et al. Incidence and risk factors of deep vein thrombosis (DVT) after total hip or knee arthroplasty: a retrospective study with routinely applied venography [J]. Blood Coagul Fibrinolysis, 2017, 28(2):126-133.
2
Jurk K, Kehrel BE. [Pathophysiology and biochemistry of platelets][J]. Internist, 2010, 51(9):1086-1094.
3
Streiff MB, Agnelli G, Connors JM, et al. Guidance for the treatment of deep vein thrombosis and pulmonary embolism [J]. J Thromb Thrombolysis, 2016, 41(1):32-67.
4
Lee SY, Ro du H, Chung CY, et al. Incidence of deep vein thrombosis after major lower limb orthopedic surgery: analysis of a nationwide claim registry [J]. Yonsei Med J 2015, 56(1):139-145.
5
Righini M, Galanaud JP, Le Gal G. Anticoagulant therapy for symptomatic calf deep vein thrombosis [J]. Lancet Haematol, 2017, 4(4):156.
6
张成梅,尹志圣,武传涛,等.吲哚布芬对血小板聚集及血栓形成的影响[J].山东大学学报:医学版, 2010, 48(12):37-41.
7
O'brien J, Duncan H, Kirsh G, et al. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial [J]. Lancet, 2000, 355(9212):1295-1302.
8
Bahl V, Hu HM, Henke PK, et al. A validation study of a retrospective venous thromboembolism risk scoring method [J]. Ann Surg, 2010, 251(2):344-350.
9
范忠诚,曹亮,张寿,等.不同氨甲环酸应用方法对老年股骨头置换术引流量的影响[J].中华老年骨科与康复电子杂志, 2018, 4(3):137-140.
10
杨雄刚,胡永成,赵立明.老年骨科患者血栓预防的研究现状[J].中华老年骨科与康复电子杂志, 2018, 4(2):65-69.
11
裴宝瑞,吴啸波,李力更,等.应用低分子肝素钙预防老年髋部骨折术前静脉血栓栓塞症的剂量研究[J].中华老年骨科与康复电子杂志, 2016, 2(2):76-80.
12
马信龙,张建敏,马剑雄,等.骨科大手术后静脉血栓栓塞症的研究进展[J].中华骨科杂志, 2016, 36(15):995-1001.
13
楚翔宇,程文俊,王俊文,等.老年股骨颈骨折全髋关节置换术围手术期下肢深静脉血栓形成的特点[J].中华老年骨科与康复电子杂志, 2018, 4(2):75-79.
14
Rostagno C. Prophylaxis of venous thromboembolism in major orthopedic surgery:a practical approach [J]. Cardiovasc Hematol Agents Med Chem, 2013, 11(3):230-242.
15
陈宾,林凤飞,林朝晖,等.低分子肝素钙治疗老年创伤后急性深静脉血栓的临床应用[J].中华老年骨科与康复电子杂志, 2018, 4(2):86-91.
16
李岚,徐燕红.改良注射法在低分子肝素钠皮下注射中的应用价值[J].内蒙古中医药, 2012, 31(7):31-32.
17
Vargas Ruiz AG, Ramírez López AN, Medina Viramontes ME. New anticoagulants: dabigatran, rivaroxaban and apixaban [J]. Gac Med Mex, 2012, 148(3):257-264.
18
Lassen MR, Haas S, Kreutz R, et al. Rivaroxaban for thromboprophylaxis after Fracture-Related orthopedic surgery in routine clinical practice [J]. Clin Appl ThrombHemost, 2016, 22(2):138-146.
19
Eriksson B, Borris LC, Friedman RJ. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty [J]. N Engl J Med, 2008, 358(26):2765-2775.
20
Stangier J. Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate [J]. Clin Pharmacokinet, 2008, 47(5):285-295.
21
中华医学会心血管病学分会,中国老年学学会心脑血管病专业委员会.老年高血压的诊断与治疗中国专家共识(2011版) [J].中国医学前沿杂志:电子版, 2012, 4(2):31-39.
22
Garry J, Duke A, Labropoulos N. Systematic review of the complications following isolated calf deep vein thrombosis [J]. BrJSurg, 2016, 103(7):789-796.
23
中华医学会神经病学分会.中华医学会神经病学分会脑血管病学组.中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2014 [J].中华神经科杂志, 2015, 48(4):258-273.
24
高乐才,吴文元,魏金栋,等.利伐沙班与低分子肝素对髋、膝关节置换术后隐性失血影响的对比观察[J].现代中西医结合杂志, 2013, 22(7):721-722.
25
顾广飞,王家骐.低分子肝素和利伐沙班在髋膝关节置换中的应用[J].国际骨科学杂志, 2010, 31(3):166-168.
26
袁磊,包倪荣,赵建宁.髋关节置换术后隐性失血的新进展[J].中国骨伤, 2015, 28(4):378-382.
27
丁水平,方淑贤.吲哚布芬治疗血栓性疾病研究进展[J].医药导报, 2006, 25(10):1039-1041.
28
Tamassia V, Corvi G, Fuccella LM, et al. Indobufen (K 3920), a new inhibitor of platelet aggregation: effect of food on bioavailability, pharmacokinetic and pharmacodynamic study during repeated oral administration to man [J]. Eur J Clin Pharmacol, 1979, 15(5):329-333.
[1] 陈晓玲, 钟永洌, 刘巧梨, 李娜, 张志奇, 廖威明, 黄桂武. 超高龄髋膝关节术后谵妄及心血管并发症风险预测[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 575-584.
[2] 陈翠萍, 李佩君, 杜景榕, 谢青梅, 许一宁, 卓姝妤, 李晓芳. 互联网联合上门护理在老年全髋关节置换术后的应用效果[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 676-681.
[3] 丁莹莹, 宋恺, 金姬延, 田华. 机器人辅助膝髋关节置换术后精细化临床护理[J/OL]. 中华关节外科杂志(电子版), 2024, 18(04): 553-557.
[4] 孔德铭, 刘铮, 李睿, 钱文伟, 王飞, 蔡道章, 柴伟. 人工智能辅助全髋关节置换三维术前规划准确性评价[J/OL]. 中华关节外科杂志(电子版), 2024, 18(04): 431-438.
[5] 曾敬, 吴冬冬, 邵明, 范震波, 王治国, 刘培谊, 兰海峰. 高龄髋部骨折患者不同手术时机的围手术期疗效评估[J/OL]. 中华关节外科杂志(电子版), 2024, 18(04): 445-449.
[6] 姚金含, 王伟娜, 张玉泉. 妊娠相关深静脉血栓形成患者的预后研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 367-373.
[7] 宋俊锋, 张珍珍. 单侧初发性腹股沟斜疝老年患者经腹腹膜前疝修补术中残余疝囊腹直肌下缘固定效果评估[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 670-674.
[8] 张晋伟, 董永红, 王家璇. 基于GBD2021 数据库对中国与全球老年人疝疾病负担和健康不平等的分析比较[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 708-716.
[9] 袁志静, 黄杰, 何国安, 方辉强. 罗哌卡因联合右美托咪定局部阻滞麻醉在老年腹腔镜下无张力疝修补术中的应用[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 557-561.
[10] 邵世锋, 肖钦, 沈方龙, 张迅, 郝志鹏, 伍正彬, 谢晓娟, 王耀丽. 老年胸主动脉钝性伤的重症救治分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 762-767.
[11] 王贝贝, 崔振义, 王静, 王晗妍, 吕红芝, 李秀婷. 老年股骨粗隆间骨折患者术后贫血预测模型的构建与验证[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 355-362.
[12] 张骞, 唐伟, 刘丽丽. 右美托咪定复合羟考酮对老年经皮椎间孔镜腰椎间盘切除术患者术后认知功能、镇痛效果的影响[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(04): 209-214.
[13] 鲁宁, 魏立友, 李亮, 张玉龙. 老年桡骨远端骨折小夹板治疗后早期腕关节功能恢复的相关因素分析[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(04): 222-228.
[14] 崔健, 夏青, 林云, 李光玲, 李心娜, 王位. 血小板与淋巴细胞比值、免疫球蛋白、心肌酶谱及心电图对中老年肝硬化患者病情及预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 400-406.
[15] 董坤, 陈海恋, 王景. 血清CircRNA_0003694与老年急性缺血性卒中患者卒中后认知损害的关系[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(03): 230-235.
阅读次数
全文


摘要